Lucid Diagnostics (LUCD) Gross Profit (QoQ) (2021 - 2026)
Lucid Diagnostics (LUCD) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Lucid Diagnostics | 131.30 Mn | 103.42 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.22% |
| Dec 31, 2025 | 25.51% |
| Sep 30, 2025 | -33.88% |
| Jun 30, 2025 | 49.79% |
| Mar 31, 2025 | 23.73% |
| Dec 31, 2024 | -85.16% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 2.60% |
| Mar 31, 2024 | -57.07% |
| Dec 31, 2023 | 51.00% |
| Sep 30, 2023 | 38.78% |
| Jun 30, 2023 | -55.83% |
| Mar 31, 2023 | -896.43% |
| Dec 31, 2022 | 47.37% |
| Mar 31, 2022 | -160.00% |
| Dec 31, 2021 | 50.00% |